Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies

Prenatal Diagnosis

Volumn 34, Issue 9, 2014, Pages 870-877

  Ciborowski, Michal ^a   Zbucka Kretowska, Monika ^a   Bomba Opon, Dorota ^b   Wielgos, Miroslaw ^b   Brawura Biskupski Samaha, Robert ^b   Pierzynski, Piotr ^a   Szmitkowski, Maciej ^a   Wolczynski, Slawomir ^a   Lipinska, Danuta ^a   Citko, Anna ^a   Bauer, Witold ^a   Gorska, Maria ^a   Kretowski, Adam ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; COLECALCIFEROL; FATTY ACID BINDING PROTEIN 4; LIPID; LYSOPHOSPHOLIPID; MONOACYLGLYCEROL; PHOSPHOLIPID;

ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; MACROSOMIA; METABOLITE; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; ADULT; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; DISCRIMINANT ANALYSIS; FEMALE; FETAL MACROSOMIA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATERNAL SERUM SCREENING TEST; METABOLOME; METABOLOMICS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DECISION SUPPORT TECHNIQUES; DISCRIMINANT ANALYSIS; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MASS SPECTROMETRY; MATERNAL SERUM SCREENING TESTS; METABOLOME; METABOLOMICS; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 84906944553     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4386     Document Type: Article

References (47)

1. Najafian M, Cheraghi M. Occurrence of fetal macrosomia rate and its maternal and neonatal complications: a 5-year cohort study. ISRN Obstet Gynecol 2012;2012:353791.
2. Bener A, Salameh KM, Yousafzai MT, et al. Pattern of maternal complications and low birth weight: associated risk factors among highly endogamous women. ISRN Obstet Gynecol 2012;2012:540495.
3. Harder T, Plagemann A, Harder A. Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 2010;39(3):746-56.
4. Byrne CD, Phillips DI. Fetal origins of adult disease: epidemiology and mechanisms. J Clin Pathol 2000;53(11):822-8.
5. Gillman MW. Epidemiological challenges in studying the fetal origins of adult chronic disease. Int J Epidemiol 2002;31(2):294-9.
6. Bukowski R, Chlebowski RT, Thune I, et al. Birth weight, breast cancer and the potential mediating hormonal environment. PLoS ONE 2012;7(7):e40199.
7. Nissen PM, Nebel C, Oksbjerg N, et al. Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. J Biomed Biotechnol 2011, DOI: 10.1155/2011/378268
8. Harder T, Roepke K, Diller N, et al. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol 2009;169(12):1428-36.
9. Andersen LG, Angquist L, Eriksson JG, et al. Birth weight, childhood body mass index and risk of coronary heart disease in adults: combined historical cohort studies. PLoS One 2010;5(11):e14126.
10. Sisk PM, Lovelady CA, Dillard RG, et al. Lactation counseling for mothers of very low birth weight infants: effect on maternal anxiety and infant intake of human milk. Pediatrics 2006;117(1):e67-75.
11. Young BE, Johnson SL, Krebs NF. Biological determinants linking infant weight gain and child obesity: current knowledge and future directions. Advances in Nutrition: An International Review Journal 2012;3(5):675-86.
12. Castorino K, Jovanovič L. Pregnancy and diabetes management: advances and controversies. Clin Chem 2011;57(2):221-30.
13. McCowan LM, Roberts CT, Dekker GA, et al. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG 2010;117(13):1599-607.
14. Hayward I, Malcoe L, Cleathero L, et al. Investigating maternal risk factors as potential targets of intervention to reduce socioeconomic inequality in small for gestational age: a population-based study. BMC Public Health 2012;12(1):333.
15. Bezerra RM, de Castro V, Sales T, et al. The Gly972Arg polymorphism in insulin receptor substrate-1 is associated with decreased birth weight in a population-based sample of Brazilian newborns. Diabetes Care 2002;25(3):550-3.
16. Beaty TH. Invited commentary: two studies of genetic control of birth weight where large data sets were available. Am J Epidemiol 2007;165(7):753-5.
17. Catalano PM, Kirwan JP. Maternal factors that determine neonatal size and body fat. Curr Diab Rep 2001;1(1):71-7.
18. Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011;6(7):1060-83.
19. Ivorra C, García-Vicent C, Chaves FJ, et al. Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med 2012;10:142.
20. Alexandre-Gouabau MC, Courant F, Moyon T, et al. Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants. J Proteome Res 2013;12(6):2764-78.
21. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17(4):448-53.
22. Shah SH, Sun J-L, Stevens RD, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J 2012;163(5):844.e1-850.e1.
23. Bahado-Singh RO, Akolekar R, Mandal R, et al. Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol 2013;208(5):371.e1-8.
24. Bahado-Singh RO, Akolekar R, Mandal R, et al. First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol 2013;208(1):58.e1-7.
25. Bahado-Singh RO, Akolekar R, Chelliah A, et al. Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol 2013;209(1):65.e1-e9.
26. Heazell AE, Bernatavicius G, Warrander L, et al. A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome. Reprod Sci 2012;19(8):863-75.
27. Shaheen R, de Francisco A, El Arifeen S, et al. Effect of prenatal food supplementation on birth weight: an observational study from Bangladesh. Am J Clin Nutr 2006;83(6):1355-61.
28. Piszcz J, Lemancewicz D, Dudzik D, et al. Differences and similarities between LC-MS derived serum fingerprints of patients with B-cell malignancies. ELECTROPHORESIS 2013;34(19):2857-64.
29. Poynard T, Halfon P, Castera L, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53(9):1615-22.
30. Campbell FM, Dutta-Roy AK. Plasma membrane fatty acid-binding protein (FABPpm) is exclusively located in the maternal facing membranes of the human placenta. FEBS Lett 1995;375(3):227-30.
31. Mishima T, Miner JH, Morizane M, et al. The expression and function of fatty acid transport protein-2 and -4 in the murine placenta. PLoS ONE 2011;6(10):e25865.
32. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008;7(6):489-503.
33. Lager S, Powell TL. Regulation of nutrient transport across the placenta. J Pregnancy 2012;2012:179827.
34. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 2011;34(9):2061-6.
35. Shangguan X, Liu F, Wang H, et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta 2009;407(1-2):58-61.
36. Roberts MF. Phospholipases: structural and functional motifs for working at an interface. FASEB J 1996;10(10):1159-72.
37. Morgan NG, Dhayal S. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem Pharmacol 2009;78(12):1419-27.
38. Liu M, Zhou M, Bao Y, et al. Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure. Clin Sci 2013;124(2):115-22.
39. Tso AWK, Xu A, Sham PC, et al. Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007;30(10):2667-72.
40. Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006;52(3):405-13.
41. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007;14(30):3209-20.
42. Park KS, Lee HY, Lee SY, et al. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. FEBS Lett 2007;581(23):4411-6.
43. Moreno-Navarrete JM, Catalán V, Whyte L, et al. The l-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes 2012;61(2):281-91.
44. Ford LA, Roelofs AJ, Anavi-Goffer S, et al. A role for l-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 2010;160(3):762-71.
45. Shin JS, Choi MY, Longtine MS, et al. Vitamin D effects on pregnancy and the placenta. Placenta 2010;31(12):1027-34.
46. Ciborowski M, Lipska A, Godzien J, et al. Combination of LC-MS- and GC-MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood. J Proteome Res 2012;11(12):6231-41.
47. Kim Y-J, Hong Y-C, Lee K-H, et al. Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol 2005;19(4):487-92.